Clinical Trial Update: A Study of the Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating topiramate as add-on therapy for primary generalized tonic-clonic seizures in epilepsy; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Epilepsy, Seizures | Phase 3 | Status: COMPLETED